Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Ultrasound Obstet Gynecol ; 54(1): 35-50, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30737852

ABSTRACT

Cardiac output (CO), along with blood pressure and vascular resistance, is one of the most important parameters of maternal hemodynamic function. Substantial changes in CO occur in normal pregnancy and in most obstetric complications. With the development of several non-invasive techniques for the measurement of CO, there is a growing interest in the determination of this parameter in pregnancy. These techniques were initially developed for use in critical-care settings and were subsequently adopted in obstetrics, often without appropriate validation for use in pregnancy. In this article, methods and devices for the measurement of CO are described and compared, and recommendations are formulated for their use in pregnancy, with the aim of standardizing the assessment of CO and peripheral vascular resistance in clinical practice and research studies on maternal hemodynamics. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Cardiac Output/physiology , Echocardiography/methods , Hemodynamics/physiology , Vascular Resistance/physiology , Adult , Blood Pressure/physiology , Catheterization, Swan-Ganz/methods , Female , Heart/diagnostic imaging , Heart/physiology , Humans , Hypertension, Pregnancy-Induced/physiopathology , Magnetic Resonance Imaging/methods , Middle Aged , Pregnancy , Pregnant Women , Pulse Wave Analysis/methods , Ultrasonography, Doppler/methods
2.
Ultrasound Obstet Gynecol ; 54(3): 350-358, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30426576

ABSTRACT

OBJECTIVE: To evaluate left ventricular (LV) mechanics in the second trimester of healthy pregnancy and to determine the influence of underpinning hemodynamics (heart rate (HR), preload and afterload) on LV mechanics during gestation. METHODS: This was a cross-sectional study of 18 non-pregnant, 14 nulliparous pregnant (22-26 weeks' gestation) and 13 primiparous postpartum (12-16 weeks after delivery) women. All pregnant and postpartum women had uncomplicated, singleton gestations. Cardiac structure and function were assessed using echocardiography. LV mechanics, specifically longitudinal strain, circumferential strain and twist/untwist, were measured using speckle-tracking echocardiography. Differences between groups were identified using ANCOVA, with age, HR, end-diastolic volume (EDV) and systolic blood pressure (SBP) as covariates. Relationships between LV mechanics and hemodynamics were examined using Pearson's correlation. RESULTS: There were no significant differences in LV structure and traditional measurements of systolic and diastolic function between the three groups. Pregnant women, compared with non-pregnant ones, had significantly higher resting longitudinal strain (-22 ± 2% vs -17 ± 3%; P = 0.002) and basal circumferential strain (-23 ± 4% vs -16 ± 2%; P = 0.001). Apical circumferential strain and LV twist and untwist mechanics were similar between the three groups. No statistically significant relationships were observed between LV mechanics and HR, EDV or SBP within the groups. CONCLUSIONS: Compared to the non-pregnant state, pregnant women in the second trimester of a healthy pregnancy have significantly greater resting systolic function, as assessed by LV longitudinal and circumferential strain. Contrary to previous work, these data show that healthy pregnant women should not exhibit reductions in resting systolic function between 22 and 26 weeks' gestation. The enhanced myocardial contractile function during gestation does not appear to be related to hemodynamic load and could be the result of other physiological adaptations to pregnancy. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Adaptation, Physiological/physiology , Pregnancy Trimester, Second/physiology , Stroke Volume/physiology , Ventricular Function, Left/physiology , Adult , Cross-Sectional Studies , Echocardiography , Female , Hemodynamics , Humans , Pregnancy , United Kingdom/epidemiology
3.
Climacteric ; 20(5): 476-483, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28786704

ABSTRACT

OBJECTIVES: Cardiovascular function generally decreases with age, but whether this decrease differs between men and women is unclear. Our aims were twofold: (1) to investigate age-related sex differences in left ventricular (LV) structure, function and mechanics, and (2) to compare these measures between pre- and postmenopausal women in the middle-aged group. METHODS: Resting echocardiography was performed in a cross-sectional sample of 82 healthy adults (14 young men, 19 middle-aged men, 15 young women, 34 middle-aged women: 15 premenopausal and 19 postmenopausal). Two-way ANOVAs were used to examine sex × age interactions, and t-tests to compare pre- and postmenopausal women (α < 0.1). RESULTS: Normalized LV mass, stroke volume and end-diastolic volume were significantly lower in middle-aged than young men, but this difference was smaller between middle-aged and young women. Peak systolic apical mechanics were significantly greater in middle-aged men than in middle-aged women, but not between young men and women. Postmenopausal women had significantly lower LV relaxation and mechanics (torsion, twisting velocity and apical circumferential strain rates) compared with middle-aged premenopausal women. CONCLUSION: Our cross-sectional findings suggest that the hearts of men and women may age differently, with men displaying greater differences in LV volumes accompanied by differences in apical mechanics.


Subject(s)
Aging/physiology , Heart Ventricles/anatomy & histology , Postmenopause/physiology , Ventricular Function, Left/physiology , Adult , Age Factors , Biomechanical Phenomena , Cross-Sectional Studies , Diastole , Female , Humans , Male , Middle Aged , Sex Factors , Stroke Volume
4.
Int J Cardiol ; 245: 263-270, 2017 Oct 15.
Article in English | MEDLINE | ID: mdl-28735755

ABSTRACT

BACKGROUND: Preclinical studies have reported that a single treadmill session performed 24h prior to doxorubicin provides cardio-protection. We aimed to characterize the acute change in cardiac function following an initial doxorubicin treatment in humans and determine whether an exercise session performed 24h prior to treatment changes this response. METHODS: Breast cancer patients were randomized to either 30min of vigorous-intensity exercise 24h prior to the first doxorubicin treatment (n=13), or no vigorous exercise for 72h prior to treatment (control, n=11). Echocardiographically-derived left ventricular volumes, longitudinal strain, twist, E/A ratio, and circulating NT-proBNP, a marker of later cardiotoxicity, were measured before and 24-48h after the treatment. RESULTS: Following treatment in the control group, NT-proBNP, end-diastolic and stroke volumes, cardiac output, E/A ratio, strain, diastolic strain rate, twist, and untwist velocity significantly increased (all p≤0.01). Whereas systemic vascular resistance (p<0.01) decreased, and ejection fraction (p=0.02) and systolic strain rate (p<0.01) increased in the exercise group only. Relative to control, the exercise group had a significantly lower NT-proBNP (p<0.01) and a 46% risk reduction of exceeding the cut-point used to exclude acute heart failure. CONCLUSION: The first doxorubicin treatment is associated with acutely increased NT-proBNP, echocardiographic parameters of myocardial relaxation, left ventricular volume overload, and changes in longitudinal strain and twist opposite in direction to documented longer-term changes. An exercise session performed 24h prior to treatment attenuated NT-proBNP release and increased systolic function. Future investigations should verify these findings in a larger cohort and across multiple courses of doxorubicin.


Subject(s)
Breast Neoplasms/physiopathology , Breast Neoplasms/therapy , Cardiotoxins/therapeutic use , Exercise Test/trends , High-Intensity Interval Training/trends , Proof of Concept Study , Adult , Blood Pressure/drug effects , Blood Pressure/physiology , Breast Neoplasms/blood , Cardiac Output/drug effects , Cardiac Output/physiology , Cardiotoxins/adverse effects , Doxorubicin/adverse effects , Doxorubicin/therapeutic use , Exercise/physiology , Female , Humans , Middle Aged , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Stroke Volume/drug effects , Stroke Volume/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...